Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2015

Open Access 01-12-2015 | Research article

Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells

Authors: Ahmed Rezk, Alaa Al-Hashimi, Warren John, Hartwig Schepker, Matthias S. Ullrich, Klaudia Brix

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Login to get access

Abstract

Background

Rhododendron leaf extracts were previously found to exert antimicrobial activities against a range of Gram-positive bacteria. In this study, we investigated which of the extracts with these antimicrobial properties would be best suited for further exploitation. Specifically, the project aims to identify biologically active compounds that affect bacterial but not mammalian cells when applied in medical treatments such as lotions for ectopic application onto skin, or as orally administered drugs.

Methods

Different concentrations of DMSO-dissolved remnants of crude methanol Rhododendron leaf extracts were incubated for 24 h with cultured epidermal keratinocytes (human HaCaT cell line) and epithelial cells of the intestinal mucosa (rat IEC6 cell line) and tested for their cytotoxic potential. In particular, the cytotoxic potencies of the compounds contained in antimicrobial Rhododendron leaf extracts were assessed by quantifying their effects on (i) plasma membrane integrity, (ii) cell viability and proliferation rates, (iii) cellular metabolism, (iv) cytoskeletal architecture, and (v) determining initiation of cell death pathways by morphological and biochemical means.

Results

Extracts of almost all Rhododendron species, when applied at 500 μg/mL, were potent in negatively affecting both keratinocytes and intestine epithelial cells, except material from R. hippophaeoides var. hippophaeoides. Extracts of R. minus and R. racemosum were non-toxic towards both mammalian cell types when used at 50 μg/mL, which was equivalent to their minimal inhibitory concentration against bacteria. At this concentration, leaf extracts from three other highly potent antimicrobial Rhododendron species proved non-cytotoxic against one or the other mammalian cell type: Extracts of R. ferrugineum were non-toxic towards IEC6 cells, and extracts of R. rubiginosum as well as R. concinnum did not affect HaCaT cells. In general, keratinocytes proved more resistant than intestine epithelial cells against the treatment with compounds contained in Rhododendron leaf extracts.

Conclusions

We conclude that leaf extracts from highly potent antimicrobial R. minus and R. racemosum are safe to use at 50 μg/mL in 24-h incubations with HaCaT keratinocytes and IEC6 intestine epithelial cells in monolayer cultures. Extracts from R. rubiginosum as well as R. concinnum or R. ferrugineum are applicable to either keratinocytes or intestinal epithelial cells, respectively. Beyond the scope of the current study, further experiments are required to identify the specific compounds contained in those Rhododendron leaf extracts that exert antimicrobial activity while being non-cytotoxic when applied onto human skin or gastrointestinal tract mucosa. Thus, this study supports the notion that detailed phytochemical profiling and compound identification is needed for characterization of the leaf extracts from specific Rhododendron species in order to exploit their components as supplementary agents in antimicrobial phyto-medical treatments.
Appendix
Available only for authorised users
Literature
1.
Semkina OA. Ointments, gels, liniments, and creams containing phytopreparations (a review). Pharm Chem J. 2005;39(7):369–74.CrossRef
2.
Fennell CW, Lindsey KL, McGaw LJ, Sparg SG, Stafford GI, Elgorashi EE, et al. Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology. J Ethnopharmacol. 2004;94(2–3):205–17.
3.
Solecki RS. Shanidar IV, a neanderthal flower burial in Northern Iraq. Science. 1975;190(4217):880–1.CrossRef
4.
Zhang X. WHO traditional medicine strategy 2002–2005. Geneva, Switzerland: World Health Organization; 2002.
5.
Farnsworth NR, D. Soejarto. Global importance of medicinal plants. The conservation of medicinal plants 1991:p. 25–51.
6.
Kim H-S. Do not put too much value on conventional medicines. J Ethnopharmacol. 2005;100(1–2):37–9.CrossRefPubMed
7.
Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1–2):72–9.CrossRefPubMed
8.
Chicca A, Pellati F, Adinolfi B, Matthias A, Massarelli I, Benvenuti S, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol. 2008;153(5):879–85.
9.
De Silva T. Industrial utilization of medicinal plants in developing countries. Rome: Medicinal plants for forest conservation and health care FAO; 1997. p. 34–44.
10.
11.
Chichilnisky, G. Property rights on biodiversity and the pharmaceutical industry. Available at SSRN 1374617 1993.
12.
King SR, Carlson TJ, Moran K. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships. J Ethnopharmacol. 1996;51(1–3):45–57.CrossRefPubMed
13.
Kartal M. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products. Phytother Res. 2007;21(2):113–9.CrossRefPubMed
14.
Cronquist A. The evolution and classification of flowering plants. Bronx, New York: New York Botanical Garden; 1968.
15.
Palombo EA. Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases. Evidence-Based Complementary and Alternative Medicine. 2011;2011:680354.
16.
Yassin GH, Koek JH, Jayaraman S, Kuhnert N. Identification of novel homologous series of polyhydroxylated theasinensins and theanaphthoquinones in the SII fraction of black tea thearubigins using ESI/HPLC tandem mass spectrometry. J Agric Food Chem. 2014;62(40):9848–59.
17.
Elliott M, Liu Y. The nine rights of medication administration: an overview. Br J Nurs. 2010;19(5):300–5.CrossRefPubMed
18.
Tam TW, Liu R, Saleem A, Arnason JT, Krantis A, Haddad PS. The effect of Cree traditional medicinal teas on the activity of human cytochrome P450-mediated metabolism. J Ethnopharmacol. 2014;155(1):841–6.
19.
Tiwari ON, Chauhan UK. Genus Rhododendron status in Sikkim Himalaya: an assessment. J Am Rhododendron Soc. 2005;59:147–53.
20.
Popescu R, Kopp B. The genus Rhododendron: an ethnopharmacological and toxicological review. J Ethnopharmacol. 2013;147(1):42–62.CrossRefPubMed
21.
Shakeel-U-Rehman, Khan R, Bhat KA, Raja AF, Shawl AS, Alam MS. Isolation, characterisation and antibacterial activity studies of coumarins from Rhododendron lepidotum Wall. ex G. Don, Ericaceae. Revista Brasileira de Farmacognosia, 2010. 20:886–90.
22.
Baral B, Vaidya GS, Maharjan BL, Da Silva JAT. Phytochemical and antimicrobial characterization of rhododendron anthopogon from high Nepalese Himalaya. Botanica Lithuanica. 2015;20(2):142–52.
23.
Kupeli E, Tatli II, Akdemir ZS, Yesilada E. Bioassay-guided isolation of anti-inflammatory and antinociceptive glycoterpenoids from the flowers of Verbascum lasianthum Boiss. ex Bentham. J Ethnopharmacol. 2007;110(3):444–50.
24.
Nisar M, Ali S, Muhammed N, Gillani SN, Shah MR, Khan H, et al. Antinociceptive and anti-inflammatory potential of Rhododendron arboreum bark. Toxicol Ind Health. 2014. Epub ahead of print.
25.
Rezk A, Nolzen J, Schepker H, Albach DC, Brix K, Ullrich MS. Phylogenetic spectrum and analysis of antibacterial activities of leaf extracts from plants of the genus Rhododendron. BMC Complement Altern Med. 2015;15(1):1–10.
26.
Seephonkai P, Popescu R, Zehl M, Krupitza G, Urban E, Kopp B. Ferruginenes a − C from Rhododendron ferrugineum and their cytotoxic evaluation. J Nat Prod. 2011;74(4):712–7.
27.
Li X, Jin H, Chen G, Yan S, Shen Y, Yang M, et al. Study advances on chemical constituents and pharmacological activities of the Tibetan medicine Dali. Nat Product Res & Development. 2008;20(6):1125–8.
28.
Niles AL, Moravec RA, Riss TL. In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening. Current Chemical Genomics. 2009;3:33–41.PubMedCentralCrossRefPubMed
29.
Thomas C, Oates PS. IEC-6 cells are an appropriate model of intestinal iron absorption in rats. J Nutr. 2002;132(4):680–7.PubMed
30.
Mayer K, Vreeman A, Qu H, Brix K. Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation. Biol Chem. 2009;390(5/6):471–80.
31.
Buth H, Luigi Buttigieg P, Ostafe R, Rehders M, Dannenmann SR, Schaschke N, et al. Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes. Eur J Cell Biol. 2007;86(11–12):747–61.
32.
Rehders M, Grosshäuser BB, Smarandache A, Sadhukhan A, Mirastschijski U, Kempf J, et al. Effects of lunar and mars dust simulants on HaCaT keratinocytes and CHO-K1 fibroblasts. Adv Space Res. 2011;47(7):1200–13.
33.
Huet O, Petit JM, Ratinaud MH, Julien R. NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. Cytometry. 1992;13(5):532–9.
34.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.CrossRefPubMed
35.
Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 1987;56(3):279–85.PubMedCentralCrossRefPubMed
36.
Arampatzidou M, Rehders M, Dauth S, Yu DM, Tedelind S, Brix K. Imaging of protease functions-current guide to spotting cysteine cathepsins in classical and novel scenes of action in mammalian epithelial cells and tissues. Ital J Anat Embryol. 2011;116(1):1–19.
37.
Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956;62(2):315–23.PubMedCentralCrossRefPubMed
38.
Cockerill FR, Wikler MA, Adler J, Dudley MN, Eliopoulos GM, Ferraro MJ, et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically. Approved Standard - Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standard Institute. 2012.
39.
Carpenter A, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O. Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100.
40.
Iwata N, Wang N, Yao X, Kitanaka S. Structures and histamine release inhibitory effects of prenylated orcinol derivatives from rhododendron dauricum1. J Nat Prod. 2004;67(7):1106–9.
41.
Bhattacharyya D. Rhododendron species and their uses with special reference to Himalayas– a review. Assam University J Sci & Technology: Biological and Environ Sci. 2011;7(1):161–7.
42.
Peng YY, Liu FH, Ye JN. Determination of bioactive flavonoids in Rhododendron dauricum L. By capillary electrophoresis with electrochemical detection. Chromatographia. 2004;60(9–10):597–602.CrossRef
43.
Cao Y, Chu Q, Ye J. Chromatographic and electrophoretic methods for pharmaceutically active compounds in Rhododendron dauricum. J Chromatogr B. 2004;812(1–2):231–40.CrossRef
44.
Zou H-Y, Luo J, Xu DR, Kong LY. Tandem Solid-Phase Extraction Followed by HPLC–ESI/QTOF/MS/MS for Rapid Screening and Structural Identification of Trace Diterpenoids in Flowers of Rhododendron molle. Phytochem Anal. 2014;25(3):255–65.
45.
Qiang Y, Zhou B, Gao K. Chemical constituents of plants from the genus Rhododendron. Chem Biodivers. 2011;8(5):792–815.CrossRefPubMed
46.
Amil-Ruiz F, Bianco-Portales R, Muñoz-Blanco J, Caballero JL. The strawberry plant defense mechanism: a molecular review. Plant Cell Physiol. 2011;52(11):1873–903.
47.
Jaiswal R, Jayasinghe L, Kuhnert N. Identification and characterization of proanthocyanidins of 16 members of the Rhododendron genus (Ericaceae) by tandem LC–MS. J Mass Spectrom. 2012;47(4):502–15.CrossRefPubMed
48.
Santos FV, Colus IM, Silva MA, Vilegas W, Varanda EA. Assessment of DNA damage by extracts and fractions of Strychnos pseudoquina, a Brazilian medicinal plant with antiulcerogenic activity. Food Chem Toxicol. 2006;44(9):1585–9.
49.
Mei N, Heflich RH, Chou MW, Chen T. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic Big blue rats. Chem Res Toxicol. 2004;17(6):814–8.
50.
Farias Vargas Junior S, Marcolongo-Pereira C, Halinski-Silveira D, Grecco FB, Raffi MB, Schild AL, et al. Rhododendron simsii poisoning in goats in Southern Brazil. Ciência Rural. 2014;44(7):1249–52.
51.
Puschner B, Holstege DM, Lamberski N. Grayanotoxin poisoning in three goats. J Am Vet Med Assoc. 2001;218(4):573–5. 527–78.
52.
Berny P, Caloni F, Croubels S, Sachana M, Vandenbroucke V, Davanzo F, et al. Animal poisoning in Europe. Part 2: companion animals. Vet J. 2010;183(3):255–9.
53.
54.
Rietjens IMCM, Boersma MG, van der Woude H, Jeurissen SMF, Schutte ME, Alink GM. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutation research/fundamental and molecular mechanisms of mutagenesis. Genes and Environment Bridging the Gap. 2005;574(1–2):124–38.
55.
Li FR, Yu FX, Yao ST, Si YH, Zhang W, Gao LL. Hyperin extracted from Manchurian rhododendron leaf induces apoptosis in human endometrial cancer cells through a mitochondrial pathway. Asian Pac J Cancer Prev. 2012;13(8):3653–6.
56.
Way TD, Tsai SJ, Wang CM, Ho CT, Chou CH. Chemical constituents of Rhododendron formosanum show pronounced growth inhibitory effect on non-small-cell lung carcinoma cells. J Agric Food Chem. 2014;62(4):875–84.
57.
58.
Metadata
Title
Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells
Authors
Ahmed Rezk
Alaa Al-Hashimi
Warren John
Hartwig Schepker
Matthias S. Ullrich
Klaudia Brix
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0860-8

Other articles of this Issue 1/2015

BMC Complementary Medicine and Therapies 1/2015 Go to the issue

Research article

The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer’s disease: a systematic review

Research article

Anti-arrhythmic effect of acupuncture pretreatment in the rats subjected to simulative global ischemia and reperfusion—involvement of intracellular Ca2+ and connexin 43

Research article

Antimicrobial and antioxidant flavonoids from the leaves of Oncoba spinosa Forssk. (Salicaceae)

Research article

Acute and subchronic in-vivo effects of Ferula hermonis L. and Sambucus nigra L. and their potential active isolates in a diabetic mouse model of neuropathic pain

Research article

Tong Luo Jiu Nao ameliorates Aβ1–40-induced cognitive impairment on adaptive behavior learning by modulating ERK/CaMKII/CREB signaling in the hippocampus

Research article

Antimicrobial potential of the Ethiopian Thymus schimperi essential oil in comparison with others against certain fungal and bacterial species